Astria Therapeutics, Inc.
US ˙ NasdaqGM ˙ US04635X1028

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Nicholas Galakatos. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Nicholas Galakatos har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:ETTX / Entasis Therapeutics Holdings Inc Director 7.500
US:NSTG / NanoString Technologies, Inc. Director, 10% Owner 4.410
US:FTSV / Forty Seven, Inc. 10% Owner 0
US:HAIR / Restoration Robotics, Inc. 10% Owner 0
US:RDUS / Radius Recycling, Inc. 2.459.804
US:CATB / Astria Therapeutics Inc Director 6.500
US:TLOG / TetraLogic Pharmaceuticals Corporation 10% Owner 2.214.523
US:SIEN / Sientra, Inc. 10% Owner 5.461.530
US:OPHT / Ophthotech Corp Director 3.945
10% Owner 2.237.377
US:AERI / Aerie Pharmaceuticals Inc 10% Owner 0
Director 10.000
US:GMED / Globus Medical, Inc. 0
US:KBIO / KaloBios Pharmaceuticals, Inc. 10% Owner 0
US:SOMX / Somaxon Pharmaceuticals, Inc. 10% Owner 1.275.886
10% Owner 3
US:ZGNX / Zogenix Inc 10% Owner 9.482.439
US:AVNR / Avanir Pharmaceuticals Inc 10% Owner 12
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Nicholas Galakatos. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ATXS / Astria Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATXS / Astria Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ATXS / Astria Therapeutics, Inc. Insider Trades
Insidersalg ATXS / Astria Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATXS / Astria Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ATXS / Astria Therapeutics, Inc. Insider Trades
Insiderkøb TLOG / TetraLogic Pharmaceuticals Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATXS / Astria Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2013-12-17 TLOG Clarus Lifesciences II, L.P. 1.425.063 7,0000 1.425.063 7,0000 9.975.441 31 12.25 7.481.581 75,00

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TLOG / TetraLogic Pharmaceuticals Corporation Insider Trades
Insidersalg TLOG / TetraLogic Pharmaceuticals Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATXS / Astria Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2016-02-09 TLOG Clarus Lifesciences II, L.P. 230.507 0,1600 230.507 0,1600 36.881 317 0.0301 -29.943 -81,19
2016-02-08 TLOG Clarus Lifesciences II, L.P. 103.123 0,1900 103.123 0,1900 19.593
2016-02-05 TLOG Clarus Lifesciences II, L.P. 832.881 0,2000 832.881 0,2000 166.576
2016-02-04 TLOG Clarus Lifesciences II, L.P. 500.026 0,1400 500.026 0,1400 70.004
2016-02-03 TLOG Clarus Lifesciences II, L.P. 82.583 0,1500 82.583 0,1500 12.387
2016-02-02 TLOG Clarus Lifesciences II, L.P. 176.306 0,1700 176.306 0,1700 29.972
2016-02-01 TLOG Clarus Lifesciences II, L.P. 140.000 0,2000 140.000 0,2000 28.000
2016-01-29 TLOG Clarus Lifesciences II, L.P. 52.826 0,2600 52.826 0,2600 13.735
2016-01-28 TLOG Clarus Lifesciences II, L.P. 32.521 0,2600 32.521 0,2600 8.455
2016-01-27 TLOG Clarus Lifesciences II, L.P. 209.984 0,2700 209.984 0,2700 56.696
2016-01-26 TLOG Clarus Lifesciences II, L.P. 69.425 0,3000 69.425 0,3000 20.828

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TLOG / TetraLogic Pharmaceuticals Corporation Insider Trades
Insiderkøb VERO / Venus Concept Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATXS / Astria Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VERO / Venus Concept Inc. Insider Trades
Insidersalg VERO / Venus Concept Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATXS / Astria Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VERO / Venus Concept Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Nicholas Galakatos som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2019-06-21 2019-06-19 4 ETTX Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
A - Award 7.500 7.500
2019-03-27 2019-03-25 4 NSTG NanoString Technologies Inc
Common Stock
A - Award 4.410 4.410
2019-01-22 2019-01-18 4 ETTX Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
A - Award 15.000 15.000
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche B Convertible Preferred Stock
C - Conversion -8.552.024 0 -100,00
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche A Convertible Preferred Stock
C - Conversion -6.702.213 0 -100,00
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B Convertible Preferred Stock
C - Conversion -7.500.000 0 -100,00
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
P - Purchase 453.395 1.623.405 38,75 15,00 6.800.925 24.351.075
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
C - Conversion 412.583 1.170.010 54,47
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
C - Conversion 323.341 685.170 89,36
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
C - Conversion 361.829 361.829
2018-09-19 2018-09-17 4 NSTG NanoString Technologies Inc
Common Stock Warrant (Right to Buy)
X - Other -162.408 0 -100,00
2018-09-19 2018-09-17 4 NSTG NanoString Technologies Inc
Common Stock
S - Sale -85.823 4.036.025 -2,08 15,99 -1.372.310 64.536.040
2018-09-19 2018-09-17 4 NSTG NanoString Technologies Inc
Common Stock
X - Other 162.408 4.121.848 4,10 8,45 1.372.023 34.821.372
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series B Preferred Stock
C - Conversion -1.922.682 0 -100,00
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-2 Preferred Stock
C - Conversion -755.780 0 -100,00
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-1 Preferred Stock
C - Conversion -938.489 0 -100,00
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
P - Purchase 200.000 3.816.951 5,53 16,00 3.200.000 61.071.216
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
C - Conversion 1.922.682 3.616.951 113,48
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
C - Conversion 755.780 1.694.269 80,53
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
C - Conversion 938.489 938.489
2018-01-03 2018-01-01 4 NSTG NanoString Technologies Inc
Common Stock
A - Award 10.168 10.168
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Series C Preferred Stock
C - Conversion -3.389.105 0 -100,00
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Convertible Promissory Note
C - Conversion 0
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock
C - Conversion 180.881 3.569.986 5,34 7,00 1.266.167 24.989.902
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock
C - Conversion 3.389.105 3.389.105
2017-10-13 2017-10-11 4 HAIR Restoration Robotics Inc
Convertible Promissory Note
J - Other 1.259.269,79
2017-01-04 2017-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 8.611 8.611
2016-09-29 2016-09-27 4 RDUS Radius Health, Inc.
Common Stock
J - Other -1.229.902 2.459.804 -33,33
2016-08-05 2016-08-03 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 6.500 6.500
2016-02-10 2016-02-09 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -230.507 2.214.523 -9,43 0,16 -36.881 354.324
2016-02-10 2016-02-08 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -103.123 2.445.030 -4,05 0,19 -19.593 464.556
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5.461.530
2016-02-05 2016-02-05 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -832.881 2.548.153 -24,63 0,20 -166.576 509.631
2016-02-05 2016-02-04 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -500.026 3.381.034 -12,88 0,14 -70.004 473.345
2016-02-05 2016-02-03 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -82.583 3.881.060 -2,08 0,15 -12.387 582.159
2016-02-02 2016-02-02 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -176.306 3.963.643 -4,26 0,17 -29.972 673.819
2016-02-02 2016-02-01 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -140.000 4.139.949 -3,27 0,20 -28.000 827.990
2016-02-02 2016-01-29 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -52.826 4.279.949 -1,22 0,26 -13.735 1.112.787
2016-01-28 2016-01-28 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -32.521 4.332.775 -0,74 0,26 -8.455 1.126.522
2016-01-28 2016-01-27 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -209.984 4.365.296 -4,59 0,27 -56.696 1.178.630
2016-01-28 2016-01-26 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -69.425 4.575.280 -1,49 0,30 -20.828 1.372.584
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -499 3.945 -11,23 65,33 -32.600 257.727
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -501 4.444 -10,13 65,45 -32.790 290.860
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1.001 5.684 -14,97 66,33 -66.396 377.020
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -999 6.685 -13,00 65,45 -65.385 437.533
2016-01-05 2016-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 7.828 7.828
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -733 4.945 -12,91 64,63 -47.374 319.595
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -267 5.678 -4,49 63,91 -17.064 362.881
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1.467 7.684 -16,03 64,63 -94.812 496.617
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -533 9.151 -5,50 63,90 -34.059 584.749
2015-11-19 2015-11-18 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 5.945 -7,76 60,00 -30.000 356.700
2015-11-19 2015-11-18 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1.000 9.684 -9,36 60,00 -60.000 581.040
2015-11-12 2015-11-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 6.445 -7,20 58,69 -29.345 378.257
2015-11-12 2015-11-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1.000 10.684 -8,56 58,69 -58.690 627.044
2015-11-12 2015-11-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 6.945 -6,72 60,00 -30.000 416.700
2015-11-12 2015-11-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1.000 11.684 -7,88 60,00 -60.000 701.040
2015-11-04 2015-11-02 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 7.445 -6,29 54,00 -27.000 402.030
2015-11-04 2015-11-02 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1.000 13.184 -7,05 54,00 -54.000 711.936
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 11.094 11.094
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -9.728.971 0 -100,00
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -20.800.000 0 -100,00
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Common Stock
P - Purchase 376.695 2.752.488 15,86 12,00 4.520.340 33.029.856
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Common Stock
C - Conversion 757.117 2.375.793 46,77
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Common Stock
C - Conversion 1.618.676 1.618.676
2015-06-29 2015-06-12 4 OPHT Ophthotech Corp.
Common Stock
G - Gift -1.020 14.184 -6,71
2015-06-17 2015-06-16 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -39.701 2.237.377 -1,74 14,30 -567.724 31.994.491
2015-06-17 2015-06-15 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -1.529 2.277.078 -0,07 14,27 -21.819 32.493.903
2015-06-12 2015-06-12 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -6.430 2.278.607 -0,28 14,25 -91.628 32.470.150
2015-06-12 2015-06-11 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -25.168 2.285.037 -1,09 14,27 -359.147 32.607.478
2015-06-10 2015-06-10 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -8.987 2.310.205 -0,39 14,32 -128.694 33.082.136
2015-06-10 2015-06-09 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -13.000 2.319.192 -0,56 14,26 -185.380 33.071.678
2015-06-10 2015-06-08 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -2.662 2.332.192 -0,11 14,25 -37.934 33.233.736
2015-06-08 2015-06-04 4 OPHT Ophthotech Corp.
Restricted Stock Units
A - Award 1.750 1.750
2015-06-08 2015-06-04 4 OPHT Ophthotech Corp.
Stock Option (Right To Buy)
A - Award 7.000 7.000
2015-06-03 2015-06-03 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -10.450 2.334.854 -0,45 14,32 -149.644 33.435.109
2015-06-03 2015-06-02 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -11.014 2.345.304 -0,47 14,25 -156.950 33.420.582
2015-06-03 2015-06-01 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -15.010 2.356.318 -0,63 14,29 -214.493 33.671.784
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other -1.554.744 0 -100,00
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other 3.137 7.945 65,25
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other 7.319 15.204 92,82
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other -1.554.744 0 -100,00
2015-03-24 2015-03-23 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -26.300 2.371.328 -1,10 14,44 -379.772 34.241.976
2015-03-24 2015-03-20 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -27.115 2.397.628 -1,12 14,53 -393.981 34.837.535
2015-03-19 2015-03-19 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -50.012 2.424.743 -2,02 14,61 -730.675 35.425.495
2015-03-19 2015-03-18 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -25.000 2.474.755 -1,00 14,68 -367.000 36.329.403
2015-03-19 2015-03-17 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -79.307 2.499.755 -3,08 14,67 -1.163.434 36.671.406
2015-01-30 2015-01-28 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
J - Other -3.139.447 0 -100,00
2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock Warrant
C - Conversion 184.812 0 -100,00
2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Series B Preferred Warrant
C - Conversion -184.812 0 -100,00
2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock
P - Purchase 321.000 3.468.494 10,20 10,00 3.210.000 34.684.940
2015-01-12 2015-01-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -175.000 3.324.259 -5,00 31,11 -5.444.250 103.417.697
2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -10.200 3.499.259 -0,29 31,11 -317.322 108.861.947
2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -13.420 3.509.459 -0,38 30,67 -411.591 107.635.108
2015-01-05 2015-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 7.307 7.307
2014-12-30 2014-12-29 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -6.214 3.522.879 -0,18 30,03 -186.606 105.792.056
2014-12-30 2014-12-26 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -74.510 3.529.093 -2,07 30,05 -2.239.026 106.049.245
2014-12-24 2014-12-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -263 3.603.603 -0,01 30,00 -7.890 108.108.090
2014-12-24 2014-12-22 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -49.441 3.603.866 -1,35 30,36 -1.501.029 109.413.372
2014-07-01 2014-06-27 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 10.000 10.000
2014-06-18 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
J - Other 2.308 4.808 92,32 44,24 102.104 212.701
2014-06-18 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
J - Other 5.385 7.885 215,40 44,24 238.227 348.825
2014-06-18 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
J - Other -1.143.844 1.554.744 -42,39 44,24 -50.602.515 68.780.320
2014-06-16 2014-06-11 4 AERI AERIE PHARMACEUTICALS INC
Option (right to buy)
A - Award 13.500 13.500
2014-06-16 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -15.482 2.698.588 -0,57 44,00 -681.208 118.737.872
2014-06-16 2014-06-13 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -82.277 2.714.070 -2,94 44,01 -3.621.225 119.453.277
2014-06-16 2014-06-12 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -47.217 2.796.347 -1,66 44,51 -2.101.657 124.467.083
2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -500 4.500 -10,00 44,32 -22.160 199.440
2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -29.217 2.843.564 -1,02 44,53 -1.301.074 126.627.886
2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -200 2.872.781 -0,01 46,80 -9.360 134.446.151
2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -36.880 2.872.981 -1,27 45,90 -1.692.630 131.857.187
2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -79.824 2.909.861 -2,67 44,66 -3.564.988 129.956.138
2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -39.362 2.989.685 -1,30 46,78 -1.841.500 139.868.526
2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -25.697 3.029.047 -0,84 46,02 -1.182.463 139.383.415
2014-06-11 2014-06-10 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
S - Sale -404 0 -100,00 23,36 -9.437
2014-06-11 2014-06-10 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
S - Sale -965 0 -100,00 23,36 -22.542
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series B Convertible Preferred
C - Conversion -91.175 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-3 Convertible Preferred Stock
C - Conversion -53.331 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -217.873 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -269.724 0 -100,00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
J - Other 694.449 3.689.706 23,18
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 399.891 2.995.257 15,41
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 255.881 2.595.366 10,94
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 1.045.351 2.339.485 80,78
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 1.294.134 1.294.134
2014-05-23 2014-05-21 4 OPHT Ophthotech Corp.
Director Stock Options (Right to Buy)
A - Award 15.000 15.000
2014-03-27 2014-02-26 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
J - Other 404 404
2014-03-27 2014-02-26 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
J - Other 965 965
2014-01-03 2014-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 5.847 5.847
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Warrants
X - Other -23.282 0 -100,00 6,40 -149.056
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Convertible Notes
C - Conversion -853.416 0 -100,00
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
C - Conversion -2.342.944 0 -100,00
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
X - Other 23.282 4.644.705 0,50 6,40 149.056 29.736.330
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
C - Conversion 853.416 4.621.423 22,65 7,00 5.973.912 32.349.961
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
C - Conversion 2.342.944 3.768.007 164,41
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
P - Purchase 1.425.063 1.425.063 7,00 9.975.441 9.975.441
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series G Preferred Ordinary Shares
C - Conversion -203.439 0 -100,00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series F Preferred Ordinary Shares
C - Conversion -553.859 0 -100,00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series E Preferred Ordinary Shares
C - Conversion -1.239.308 0 -100,00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion -582.456 0 -100,00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 203.439 2.579.062 8,56
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 553.859 2.375.623 30,40
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 1.239.308 1.821.764 212,77
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 582.456 582.456
2013-11-20 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
P - Purchase 2.500 2.500 22,00 55.000 55.000
2013-11-20 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
P - Purchase 2.500 2.500 22,00 55.000 55.000
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Convertible Notes
C - Conversion -420.222 0 -100,00
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Warrants
C - Conversion -184.812 0 -100,00
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Convertible Preferred Stock
C - Conversion -2.727.272 0 -100,00
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
P - Purchase 321.000 3.653.306 9,63 10,00 3.210.000 36.533.060
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
C - Conversion 184.812 3.332.306 5,87 0,05 9.241 166.615
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
C - Conversion 420.222 3.147.494 15,41
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
C - Conversion 2.727.272 2.727.272
2013-10-25 2013-10-23 4 OPHT Ophthotech Corp.
Stock Option (Right to Buy)
A - Award 22.033 22.033
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series C Preferred Stock
C - Conversion -186.027 0 -100,00
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series B Preferred Stock
C - Conversion -2.542.373 0 -100,00
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
C - Conversion 186.027 2.728.390 7,32
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
C - Conversion 2.542.373 2.542.373
2013-09-04 2013-09-03 4 GMED GLOBUS MEDICAL INC
Class A Common Stock
J - Other -7.244.201 0 -100,00
2013-07-12 2013-07-10 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 8.768 8.768
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock Warrant (Right to Buy)
C - Conversion 162.408 162.408 8,45 1.372.348 1.372.348
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series D Preferred Warrant (Right to Buy)
C - Conversion -162.408 0 -100,00 8,45 -1.372.348
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series E Preferred Stock
C - Conversion -148.342 0 -100,00
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series D Preferred Stock
C - Conversion -812.045 0 -100,00
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series C Preferred Stock
C - Conversion -2.249.053 0 -100,00
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
A - Award 750.000 3.959.440 23,37 10,00 7.500.000 39.594.400
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
C - Conversion 148.342 3.209.440 4,85
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
C - Conversion 812.045 3.061.098 36,11
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
C - Conversion 2.249.053 2.249.053
2013-06-07 2013-06-05 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 14.101 14.101
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -120.566 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -8.106 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -3.641 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -10.189 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -2.334 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -550.530 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -37.016 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -16.625 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -46.526 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -10.658 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -553.204 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -37.196 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -16.707 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -46.752 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -10.710 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -807.939 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -54.323 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -24.400 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -68.280 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -15.642 0 -100,00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 2.032.239 2.032.239
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 136.641 136.641
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 61.373 61.373
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 171.747 171.747
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 39.344 39.344
2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Common Stock Warrant
P - Purchase 227.939 0 -100,00 6,14 1.400.001
2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Series B Convertible Preferred Stock
P - Purchase 91.175 0 -100,00 61,42 5.599.968
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -275.539 0 -100,00
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -337.622 0 -100,00
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series B-2 Preferred Stock
C - Conversion -1.949.879 0 -100,00
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 313.527 2.632.928 13,52
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 369.522 2.319.401 18,95
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 1.949.879 1.949.879
2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Series E Preferred Stock
C - Conversion -7.444.168 0 -100,00
2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock
S - Sale -804.232 7.244.201 -9,99 11,16 -8.975.229 80.845.283
2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock
C - Conversion 7.444.168 8.048.433 1.231,94
2012-08-02 3 GMED GLOBUS MEDICAL INC
Class A Common Stock
604.265
2012-07-10 2012-07-09 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.624.574 1.275.886 -56,01 0,31 -498.744 391.697
2012-07-10 2012-07-06 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -671.217 2.900.460 -18,79 0,29 -195.324 844.034
2012-07-05 2012-07-03 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -98.210 3.571.677 -2,68 0,29 -28.481 1.035.786
2012-07-05 2012-07-02 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -80.348 3.669.887 -2,14 0,29 -23.301 1.064.267
2012-07-02 2012-06-28 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -19.500 3.750.235 -0,52 0,29 -5.655 1.087.568
2012-06-21 2012-06-19 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -12.000 3.759.735 -0,32 0,29 -3.480 1.090.323
2012-06-19 2012-06-15 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -1.450 3.781.735 -0,04 0,29 -420 1.096.703
2012-06-07 2012-06-06 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -8.400 3.783.185 -0,22 0,29 -2.436 1.097.124
2012-06-07 2012-06-05 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -29.555 3.791.585 -0,77 0,29 -8.571 1.099.560
2012-06-06 2012-06-04 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -10.942.468 3 -100,00
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy)
X - Other -1.290.922 0 -100,00
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy)
X - Other -1.706.426 0 -100,00
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -708.810 10.942.471 -6,08 7,49 -5.311.255 81.994.124
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -608.146 11.651.281 -4,96 7,49 -4.556.960 87.305.379
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
X - Other 1.706.426 12.259.427 16,17 3,11 5.311.251 38.157.467
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
X - Other 1.290.922 10.553.001 13,94 3,53 4.556.955 37.252.094
2012-06-04 2012-05-31 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -29.850 3.821.140 -0,78 0,30 -8.955 1.146.342
2012-06-04 2012-05-30 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -51.007 3.850.990 -1,31 0,30 -15.302 1.155.297
2012-06-04 2012-05-29 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -15.300 3.901.997 -0,39 0,30 -4.622 1.178.793
2012-06-04 2012-05-25 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -293.015 3.917.297 -6,96 0,30 -87.904 1.175.189
2012-06-04 2012-05-23 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -135.250 4.210.312 -3,11 0,30 -40.629 1.264.778
2012-06-04 2012-05-22 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -287.000 4.345.562 -6,20 0,30 -86.990 1.317.140
2011-09-20 2011-09-16 4 ZGNX ZOGENIX, INC.
Common Stock
P - Purchase 3.500.000 9.482.439 58,50 2,00 7.000.000 18.964.878
2010-12-07 2010-12-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
J - Other -6.669.204 12 -100,00
2010-11-10 2010-11-09 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.200.000 6.669.216 -15,25 4,81 -5.773.920 32.089.600
2010-11-10 2010-11-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -44.626 7.869.216 -0,56 5,10 -227.593 40.133.002
2010-11-05 2010-11-05 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -332.572 7.913.842 -4,03 4,80 -1.597.377 38.010.975
2010-11-05 2010-11-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.400.106 8.246.414 -14,51 4,52 -6.332.539 37.297.706
2010-11-02 2010-11-02 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.290.871 9.646.520 -11,80 4,49 -5.800.400 43.345.673
2010-11-02 2010-11-01 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.478.142 10.937.391 -18,47 5,36 -13.273.424 58.582.854
2010-11-02 2010-10-29 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.424.947 13.415.533 -9,60 5,06 -7.215.647 67.933.576
2010-10-12 2010-10-11 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -311.000 14.840.480 -2,05 3,52 -1.093.445 52.177.644
2010-10-12 2010-10-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -240.838 15.151.480 -1,56 3,47 -836.792 52.643.817
2010-07-15 2010-07-13 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -165.000 15.392.318 -1,06 3,53 -583.143 54.399.530
2008-04-11 3 AVNR AVANIR PHARMACEUTICALS
Class A Common Stock
15.557.318
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)